GasLog Ltd. and GasLog Partners LP Appoint Alastair Maxwell as Chief Financial Officer
Feb 01, 2017 12:01 pm UTC| Business
MONACO - February 1, 2017 - GasLog Ltd. (NYSE:GLOG) ("GasLog") and GasLog Partners LP (NYSE:GLOP) ("GasLog Partners" or the "Partnership") announced today that, following Simon Crowe's decision to step down from his...
Feb 01, 2017 12:01 pm UTC| Business
OXFORD, United Kingdom, Feb. 01, 2017 -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection...
Feb 01, 2017 12:01 pm UTC| Business
OXFORD, United Kingdom, Feb. 01, 2017 -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection...
Natus Medical Announces Fourth Quarter and Full Year 2016 Financial Results
Feb 01, 2017 12:01 pm UTC| Business
Reports fourth quarter revenue of $107.7 million and full year revenue of $381.9 millionReports fourth quarter GAAP earnings per share of $0.31 and non-GAAP of $0.51PLEASANTON, Calif., Feb. 01, 2017 -- Natus Medical...
Natus Medical Announces Fourth Quarter and Full Year 2016 Financial Results
Feb 01, 2017 12:01 pm UTC| Business
Reports fourth quarter revenue of $107.7 million and full year revenue of $381.9 millionReports fourth quarter GAAP earnings per share of $0.31 and non-GAAP of $0.51PLEASANTON, Calif., Feb. 01, 2017 -- Natus Medical...
Feb 01, 2017 12:00 pm UTC| Business
SALT LAKE CITY, Feb. 01, 2017 -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the completion of the clinical trial and 510(k) submission to the Food and Drug Administration...
ADP Reports Second Quarter Fiscal 2017 Results
Feb 01, 2017 12:00 pm UTC| Business
Revenues increased 6% to $3.0 billion for the quarter, 7% on a constant dollar basisDiluted earnings per share from continuing operations increased 53% to $1.13; adjusted diluted earnings per share from continuing...